These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Altundag O, Gullu I, Altundag K, Yalcin S, Ozyar E, Cengiz M, Akyol F, Yucel T, Hosal S, Sozeri B. Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158 [Abstract] [Full Text] [Related]
7. Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers. Clayman GL, Weber RS, Guillamondegui O, Byers RM, Wolf PF, Frankenthaler RA, Morrison WH, Garden AS, Hong WK, Goepfert H. Arch Otolaryngol Head Neck Surg; 1995 Feb; 121(2):219-23. PubMed ID: 7840931 [Abstract] [Full Text] [Related]
8. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation. Janoray G, Pointreau Y, Garaud P, Chapet S, Alfonsi M, Sire C, Jadaud E, Calais G. J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800 [Abstract] [Full Text] [Related]
13. [Induction chemotherapy and larynx preservation: is such practice useful?]. Sarini J, Bocciolini C, Fournier C, Penel N, Kara A, Van JT, Lefebvre JL. Bull Cancer; 2002 Apr 01; 89(4):411-7. PubMed ID: 12016041 [Abstract] [Full Text] [Related]
17. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, Taylor J. J Clin Oncol; 2006 Feb 01; 24(4):593-8. PubMed ID: 16380415 [Abstract] [Full Text] [Related]
19. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS, Rosenthal DI. Am J Clin Oncol; 2005 Aug 01; 28(4):385-92. PubMed ID: 16062081 [Abstract] [Full Text] [Related]
20. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, Hagen R, Pfreundner L, Schröder U, Eckel H, Hess M, Schröder M, Schneider P, Jens B, Zenner HP, Werner JA, Engenhardt-Cabillic R, Vanselow B, Plinkert P, Niewald M, Kuhnt T, Budach W, Flentje M. Eur Arch Otorhinolaryngol; 2009 Aug 01; 266(8):1291-300. PubMed ID: 18972123 [Abstract] [Full Text] [Related] Page: [Next] [New Search]